Saturday, November 21, 2026 Vol. I · No. 9
Health · Via The Hill

Overton’s nomination withdrawal means no clear end for FDA leadership vacuum

Image: The Hill

The White House’s abrupt withdrawal of Heidi Overton as President Trump’s nominee to lead the Food and Drug Administration (FDA) means the agency will remain without stable leadership six months after the former commissioner resigned, leaving industry observers anxious. The Trump administration’s…

This is a brief. The reporting belongs to The Hill — read the complete story, with full context and credits, at the source.

Read the full story at The Hill ↗

thehill.com

More from the Health desk